• Upside in revenue for the period was largely due to early double digit growth in revenue of healthcare and consumer business. The safety & Industrial (S&I) business of the company registered flat growth in revenue to Rs 285.87 crore (or 37% of total sales). The segment revenue of Transportation & Electronics (T&E), other major contributor to revenue, has registered a marginal 2% growth in revenue to Rs 245.61 crore (or 32% of sales). However the segment revenue of Healthcare and Consumer was up by 10% (to Rs 131.65 crore or 17% of total sales) and 14% (to Rs 92.74 crore or 12% of total sales). The segment revenue of others was up by 2% to Rs 7.66 crore.
• The EBIT was up by 27% to Rs 115.76 crore and the upside is largely due to strong growth in profitability of both healthcare and consumer. The S&I segment despite flat growth in revenue have reported early double digit growth in segment profit, which grew by 12% to Rs 47.21 crore. This was largely due to 180 bps expansion in segment margin of S&I business to 16.5%. On the other hand despite margin rise in sales, hit by 60 bps drop in margin to 7.3%, the segment profit of T&E business was down by 6% to Rs 17.93 crore. Riding on strong early double digit growth in revenue backed by strong 680 bps expansion in segment margin, the segment profit of healthcare was up by sharp 66% to Rs 26.28 crore. Similarly facilitated by higher sales and 950 bps expansion in segment margin to 23.9%, the segment profit of consumer jumped up by 89% to Rs 22.16 crore.

Half yearly performance

Consolidated sales was up by 6% to Rs 1568.02 crore driven largely by growth in revenue of all the four core business segments of the company. The segment revenue of S&I was up by 4% to Rs 593.30 crore and that of T&E was up by 5% to Rs 529.89 crore. The segment revenue of healthcare and consumer was up by 8% and 11% respectively to Rs 261.28 crore and Rs 171.19 crore.

But with OPM contract by 30 bps to 17.6%, the operating profit was up by 4% to Rs 276.24 crore facilitated largely by higher sales. After accounting for lower other income, higher interest and higher depreciation, the PBT was flat at Rs 264.19 crore. But a 19% fall in taxation to Rs 74.05 crore saw the PAT up by 10% to Rs 190.14 crore.

The EBIT was up by 2% to Rs 247.55 crore as the two large segments of the company i.e. S&I and T&E register lower segment profit for the period. S&I registered 3% fall in segment profit to Rs 104.45 crore and the T&E registered 10% fall in segment profit to Rs 53.88 crore. Despite higher sales the fall in segment profit for both S&I and T&E business of the company is largely due to 120 bps and 170 bps erosion in their segment margin respectively to 17.6% and 10.2%. The segment profit of healthcare was up by 5% to Rs 48.58 crore riding largely on higher sales as it segment margin eroded by 70 bps to 18.6%. However riding on higher sales as well as 560 bps expansion in segment margin to 22.3%, the segment profit of consumer was up by 48% to Rs 38.21 crore.